1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Pulmonary Diseases: new trials by email Literature Review of Pulmonary Diseases trials Research Report on Pulmonary Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®) - Pulmonary Diseases, Neoplasms, Lung | Phase 2 | Completed | Sanofi | 98 | 2006-01-01 | 2012-12-10 |
Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Disease (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
aflibercept (1)
Sanofi (1)
Canada (1) · France (1) · United States (1)